Navigation Links
Watson Pharmaceuticals Reports Second Quarter 2008 Results
Date:8/6/2008

$36,409 $110,932 $68,021

Adjusted for:

Global supply chain initiative(1) 5,423 - 19,164 -

Acquisition and licensing charges 500 2,217 5,500 9,578

Gain on sale of assets - (683) (1,355) (2,472)

Loss on debt repurchases - 1,681 1,095 4,410

Legal settlements (15,000) (842) (15,000) 158

Income taxes 3,368 (869) (3,674) (4,478)

Adjusted net income 54,594 37,913 116,662 75,217

Add: Interest expense on CODES,

net of tax 1,945 2,058 3,931 4,001

Adjusted net income, adjusted for

interest on CODES $56,539 $39,971 $120,593 $79,218

Diluted earnings per share

Diluted earnings per share - GAAP $0.53 $0.33 $0.98 $0.62

Diluted earnings per share - Adjusted $0.48 $0.34 $1.03 $0.68

Basic weighted average common

shares outstanding 102,728 102,093 102,676 102,178

Effect of dilutive securities:

Conversion of CODES 14,357 14,357 14,357 14,357

Dilutive stock options 567 630 478 374

Diluted weighted average common

shares outstanding 117,652 117,080 117,511 116,909

(1) Includes accelerated depreciation charges of $1,757 and $3,793,

respectively.

The following table presents a reconciliation of reported net income for the three and six months ended June 30, 2008 and 2007 to adjusted EBITDA:

Table 5

Watson Pharmaceuticals, Inc.

Adjusted EBITDA Reconciliation Table

(Unaudited; in millions) '/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Watson Receives FDA Approval for Generic Accuneb(R)
3. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
4. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
5. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
6. Barr Subsidiary Sues Watson for SEASONIQUE(R) Patent Infringement
7. Watson Files FDA Application for Generic LYBREL(R)
8. FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceuticals TRELSTAR(R) DEPOT and TRELSTAR(R) LA
9. Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
10. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
11. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Crystal Diagnostics (CDx) Xpress System, ... has received AOAC-PTM Certifications for the six non-O157 Shiga toxin-producing ... collectively referred to as STEC or the “Big-6”) as well ... unit (cfu) per 325 g of raw ground beef and ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Selexis SA, ... mammalian Research Cell Banks (RCBs) used for drug discovery ... Cell Banks will include Next-Generation Sequencing (NGS) ... architecture de-risks biologic manufacturing by ensuring the integrity of ...
(Date:1/22/2015)... CAMBRIDGE, Mass. , Jan. 22, 2015   GenoSpace , ... suite of tools to enable the broad use of genomic, ... today announced the appointment of Michelle Munson , CEO ... independent director. Logo - http://photos.prnewswire.com/prnh/20150122/170713 ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that the Company closed ... Oracle Investment Management, Jack W. Schuler , ... proceeds were $10.5 million, before offering expenses.  The ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... 20. Juni 2008 / b3c newswire / ... Herstellung moderner biopharmazeutischer Arzneimittel gibt die Inbetriebnahme ... das Unternehmen nun über neun unabhängige GMP-Produktionslinien ... 2.500 Litern für die Herstellung von klinischen ...
... DEARBORN, Mich., June 20 The United States Council ... Ford Motor,Company and General Motors Corporation, welcomed the addition ... as announced by,the U.S. Department of Energy (DOE) today ... Mich., DTE Energy and Southern California Edison were ...
... for Sales and Clinical Services, ST. LOUIS, ... that it has enhanced its senior management team ... appointment of Louis,Ruggiero as Senior Vice President, North ... Marketing Officer at DJ Orthopedics, formerly was,President and ...
Cached Biology Technology:Rentschler Biotechnologie erweitert Kapazitten fr Produktion in Sugetierzellen 2U.S. Automakers Welcome Utility Partners To FreedomCAR and Fuel Partnership 2U.S. Automakers Welcome Utility Partners To FreedomCAR and Fuel Partnership 3U.S. Automakers Welcome Utility Partners To FreedomCAR and Fuel Partnership 4Stereotaxis Appoints Senior Vice President, North America 2Stereotaxis Appoints Senior Vice President, North America 3
(Date:12/17/2014)... Va. , Dec. 15, 2014 The Defense ... easier to detect and prevent counterfeit microcircuits from entering ... started performing an in-house microcircuit anti-counterfeit initiative dubbed DNA ... microcircuits while increasing their reliability throughout the supply chain. ...
(Date:12/17/2014)... fundamentally transforming the travel experience and nowhere is this ... decade, ePassports, biometric readers, and secure document scanners have ... via eGates and Automated Passport Control (APC) Kiosks at ... across the globe. According to ...
(Date:12/11/2014)... Dec. 10, 2014  That blood pressure plays a role in ... – the medical term for high blood pressure – was ... the inflatable cuff that,s used in measuring blood pressure was ... nothing new about hypertension, its triggers and its effects. In ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... million tons of plastic are placed in U.S. landfills each ... that some of the largely petroleum-based plastic may soon be ... the carbon footprint and the dependence on foreign oil, this ... for farmers. "Making plastics from plants is not a ...
... and Technology (NIST) has developed a new certified ... assurance tool for measuring the amounts of vitamins, ... new Standard Reference Material (SRM) 3280 for multivitamin/multimineral ... of Dietary Supplements (ODS) at the National Institutes ...
... species of lice that infest humans: pubic lice, Pthirus ... humanus . A new article in BioMed Central,s open access ... separation of the two species. In the ... was struck by inspiration while pondering the question of why ...
Cached Biology News:'Green' plastics could help reduce carbon footprint 2New reference material can improve testing of multivitamin tablets 2
Sheep polyclonal to Salmonella Shoreditch ( Abpromise for all tested applications). Antigen: Native Salmonella shoreditch (Group D2)....
Rabbit polyclonal to ZA20D3 ( Abpromise for all tested applications). entrezGeneID: 54469 SwissProtID: Q6FIF0...
... ( Abpromise for all tested applications). ... KLH derived from within residues 1 - 100 ... sequence is proprietary) (Peptide available ... Gene ID: 5453 Swiss ...
ATP-binding cassette sub-family D member 4 (Peroxisomal membrane protein 69) (PMP69) (Peroxisomal membrane protein 1-like) (PXMP1-L) (P70R). [Source:Uniprot/SWISSPROT;Acc:O14678] Antigen: Recombi...
Biology Products: